Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes

被引:64
作者
Hill, Deirdre A.
Wang, Sophia S.
Cerhan, James R.
Davis, Scott
Cozen, Wendy
Severson, Richard K.
Hartge, Patricia
Wacholder, Sholom
Yeager, Meredith
Chanock, Stephen J.
Rothman, Nathaniel
机构
[1] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Sch Med, Ctr Canc, Albuquerque, NM 87131 USA
[3] DHHS, Div Canc Epidemiol & Genet, NCI, NIH, Bethesda, MD USA
[4] Univ Iowa, Iowa City, IA USA
[5] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA
[6] Univ Washington, Seattle, WA 98195 USA
[7] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[8] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA
[9] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[10] Wayne State Univ, Dept Family Med, Detroit, MI USA
[11] DHHS, Core Genotyping Facil, Adv Technol Corp, NCI,NIH, Gaithersburg, MD USA
关键词
D O I
10.1182/blood-2005-01-026690
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chromosomal translocations, insertions, and deletions are common early events in non-Hodgkin lymphoma (NHL) carcinogenesis, and implicated in their formation are endogenous processes involved in antigen-receptor diversification, such as V(D)J recombination. DNA repair genes respond to the double- and single-strand breaks induced by these processes and may influence NHL etiology. We examined 34 genetic variants in 19 genes within or related to 5 DNA repair pathways among 1172 cases and 982 matched controls who participated in a population-based NHL study in Los Angeles, Seattle, Detroit, and Iowa from 1998 to 2000. Cases were more likely than controls to have the RAG1 820 R/R (odds ratio [OR] = 2.7; 95% confidence interval [CI] = 1.4 to 5.0) than Lys/Lys genotypes, with evidence of a gene dosage effect (P trend <.001), and less likely to have the LIG4 (DNA ligase IV) 9 Ile/Ile (OR = 0.5; 95% Cl = 0.3 to 0.9) than TIT genotype (P trend =.03) in the nonhomologous end joining (NHEJ)/V(D)J pathway. These NHEJ/V(D)J-related gene variants represent promising candidates for further studies of NHL etiology and require replication in other studies.
引用
收藏
页码:3161 / 3167
页数:7
相关论文
共 43 条
[31]   Frequent chromosomal translocations induced by DNA double-strand breaks [J].
Richardson, C ;
Jasin, M .
NATURE, 2000, 405 (6787) :697-700
[32]   Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination [J].
Roddam, PL ;
Rollinson, S ;
O'Driscoll, M ;
Jeggo, PA ;
Jack, A ;
Morgan, GJ .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (12) :900-905
[33]   Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma:: a report from the InterLymph Consortium [J].
Rothman, N ;
Skibola, CF ;
Wang, SS ;
Morgan, G ;
Lon, Q ;
Smith, MT ;
Spinelli, JJ ;
Willett, E ;
De Sanjose, S ;
Cocco, P ;
Berndt, SI ;
Brennan, P ;
Brooks-Wilson, A ;
Wacholder, S ;
Becker, N ;
Hartge, P ;
Zheng, TZ ;
Roman, E ;
Holly, EA ;
Boffetta, P ;
Armstrong, B ;
Cozen, W ;
Linet, M ;
Bosch, FX ;
Ennas, MG ;
Holford, TR ;
Gallagher, RP ;
Rollinson, S ;
Bracci, PM ;
Cerhan, JR ;
Whitby, D ;
Moore, PS ;
Leaderer, B ;
Lai, A ;
Spink, C ;
Davis, S ;
Bosch, R ;
Scarpa, A ;
Zhang, YW ;
Severson, RK ;
Yeager, M ;
Chanock, S ;
Nieters, A .
LANCET ONCOLOGY, 2006, 7 (01) :27-38
[34]  
SHIRAMIZU B, 1990, BLOOD, V75, P1848
[35]   Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma [J].
Smedby, KE ;
Lindgren, CM ;
Hjalgrim, H ;
Humphreys, K ;
Schöllkopf, C ;
Chang, ET ;
Roos, G ;
Ryder, LP ;
Falk, KI ;
Palmgren, J ;
Kere, J ;
Melbye, M ;
Glimelius, B ;
Adami, HO .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (02) :258-265
[36]   Ultraviolet radiation exposure and risk of malignant lymphomas [J].
Smedby, KE ;
Hjalgrim, H ;
Melbye, M ;
Torrång, A ;
Rostgaard, K ;
Munksgaard, L ;
Adami, J ;
Hansen, M ;
Porwit-MacDonald, A ;
Jensen, BA ;
Roos, G ;
Pedersen, BB ;
Sundström, C ;
Glimelius, B ;
Adami, HO .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (03) :199-209
[37]  
Spurdle AB, 2002, CANCER EPIDEM BIOMAR, V11, P413
[38]   CLUSTERING OF BREAKPOINTS ON CHROMOSOME-11 IN HUMAN B-CELL NEOPLASMS WITH THE T(11-14) CHROMOSOME-TRANSLOCATION [J].
TSUJIMOTO, Y ;
JAFFE, E ;
COSSMAN, J ;
GORHAM, J ;
NOWELL, PC ;
CROCE, CM .
NATURE, 1985, 315 (6017) :340-343
[39]   V(D)J recombination defects in lymphocytes due to RAG mutations:: severe immunodeficiency with a spectrum of clinical presentations [J].
Villa, A ;
Sobacchi, C ;
Notarangelo, LD ;
Bozzi, F ;
Abinun, M ;
Abrahamsen, TG ;
Arkwright, PD ;
Baniyash, M ;
Brooks, EG ;
Conley, ME ;
Cortes, P ;
Duse, M ;
Fasth, A ;
Filipovich, AM ;
Infante, AJ ;
Jones, A ;
Mazzolari, E ;
Muller, SM ;
Pasic, S ;
Rechavi, G ;
Sacco, MG ;
Santagata, S ;
Schroeder, ML ;
Seger, R ;
Strina, D ;
Ugazio, A ;
Väliaho, J ;
Vihinen, M ;
Vogler, LB ;
Ochs, H ;
Vezzoni, P ;
Friedrich, W ;
Schwarz, K .
BLOOD, 2001, 97 (01) :81-88
[40]   Assessing the probability that a positive report is false: An approach for molecular epidemiology studies [J].
Wacholder, S ;
Chanock, S ;
Garcia-Closas, M ;
El ghormli, L ;
Rothman, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (06) :434-442